000			02038 a2200565 4500
005			20250516073358.0
264		0	_c20121213
008			201212s 0 0 eng d
022			_a1476-5594
024	7		_a10.1038/onc.2011.617 _2doi
040			_aNLM _beng _cNLM
100	1		_aAstanehe, A
245	0	0	_aMKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition. _h[electronic resource]
260			_bOncogene _cOct 2012
300			_a4434-46 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Monoclonal, Humanized _xpharmacology
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis
650	0	4	_aBase Sequence
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aChromatin Immunoprecipitation
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGene Knockdown Techniques
650	0	4	_aHumans
650	0	4	_aIntracellular Signaling Peptides and Proteins _xgenetics
650	0	4	_aPhosphorylation
650	0	4	_aProtein Array Analysis
650	0	4	_aProtein Processing, Post-Translational
650	0	4	_aProtein Serine-Threonine Kinases _xgenetics
650	0	4	_aPteridines _xpharmacology
650	0	4	_aRibosomal Protein S6 Kinases, 90-kDa _xantagonists & inhibitors
650	0	4	_aSequence Analysis, DNA
650	0	4	_aTranscription, Genetic
650	0	4	_aTrastuzumab
650	0	4	_aY-Box-Binding Protein 1 _xmetabolism
700	1		_aFinkbeiner, M R
700	1		_aKrzywinski, M
700	1		_aFotovati, A
700	1		_aDhillon, J
700	1		_aBerquin, I M
700	1		_aMills, G B
700	1		_aMarra, M A
700	1		_aDunn, S E
773	0		_tOncogene _gvol. 31 _gno. 41 _gp. 4434-46
856	4	0	_uhttps://doi.org/10.1038/onc.2011.617 _zAvailable from publisher's website
999			_c21464948 _d21464948